20 Grants
2011
Replicative Adenovirus and Anti-angiogenic Therapy
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA118218-05), $279,215USD, 06/01/2007 -- 05/31/2013
2010
Replicative Adenovirus and Anti-angiogenic Therapy
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA118218-04), $287,850USD, 06/01/2007 -- 05/31/2012
2009
Replicative Adenovirus and Anti-angiogenic Therapy
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA118218-03), $287,850USD, 06/01/2007 -- 05/31/2012
2008
Replicative Adenovirus and Anti-angiogenic Therapy
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA118218-02), $287,850USD, 06/01/2007 -- 05/31/2012
 
Tissue Specific Gene Therapy for Human Prostate Cancer
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074042-11), $265,033USD, 04/01/1997 -- 05/31/2010
2007
Replicative Adenovirus and Anti-angiogenic Therapy
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA118218-01A2), $287,850USD, 06/01/2007 -- 05/31/2012
 
Tissue Specific Gene Therapy for Human Prostate Cancer
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074042-10), $265,033USD, 04/01/1997 -- 05/31/2009
2006
Tissue Specific Gene Therapy for Human Prostate Cancer
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074042-09), $272,949USD, 04/01/1997 -- 05/31/2009
2005
Tissue Specific Gene Therapy for Human Prostate Cancer
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA074042-08), $279,518USD, 04/01/1997 -- 06/30/2009
2004
Tissue Specific Gene Therapy for Human Prostate Cancer
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 2R01CA074042-07A2), $279,518USD, 04/01/1997 -- 06/30/2009
2003
TISSUE SPECIFIC GENE THERAPY FOR PULMONARY METASTASIS
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA080825-03), $283,286USD, 01/04/2001 -- 12/31/2004
2002
TISSUE SPECIFIC GENE THERAPY FOR PULMONARY METASTASIS
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R01CA080825-02), $283,286USD, 01/04/2001 -- 12/31/2003
2001
TISSUE SPECIFIC GENE THERAPY FOR HUMAN PROSTATE CANCER
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA074042-06), $109,429USD, 04/01/1997 -- 11/30/2003
 
TISSUE SPECIFIC GENE THERAPY FOR PULMONARY METASTASIS
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R01CA080825-01A2), $283,286USD, 01/04/2001 -- 12/31/2003
2000
TISSUE SPECIFIC GENE THERAPY FOR HUMAN PROSTATE CANCER
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R29CA074042-05), $88,366USD, 04/01/1997 -- 05/31/2002
 
TISSUE SPECIFIC GENE THERAPY FOR HUMAN PROSTATE CANCER
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA074042-04), $18,057USD, 04/01/1997 -- 05/31/2000
1999
TISSUE SPECIFIC GENE THERAPY FOR HUMAN PROSTATE CANCER
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA074042-03), 04/01/1997 -- 03/31/2002
1998
TISSUE SPECIFIC GENE THERAPY FOR HUMAN PROSTATE CANCER
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R29CA074042-02), 04/01/1997 -- 03/31/2002
1997
Tissue Specific Gene Therapy for Human Prostate Cancer
Kao, Chinghai
National Institutes of Health (NIH), NATIONAL CANCER INSTITUTE (ID: 2R01CA074042-07A2), 01-APR-1997 -- 30-JUN-2009
 
TISSUE SPECIFIC GENE THERAPY FOR HUMAN PROSTATE CANCER
Kao, Chinghai
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R29CA074042-01), 04/01/1997 -- 03/31/2002